SIC
SRPT icon

Salem Investment Counselors’s Sarepta Therapeutics SRPT Stock Holding History

Salem Investment Counselors’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-201
Closed -$18K – 1101
2021
Q4 		$18K Hold
201
– – ﹤0.01% 727
2021
Q3 		$19K Buy
+201
New +$15.5K ﹤0.01% 658

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Salem Investment Counselors's SRPT Position: Q1 2022 in Review

Salem Investment Counselors sold out of Sarepta Therapeutics (SRPT) in Q1 2022, closing a stake of 201 shares — an estimated $18K sold.

Salem Investment Counselors first reported a position in SRPT in Q3 2021 and held it in 2 quarters. The position peaked at $19K in Q3 2021. 329 funds tracked by Wall St. Rank hold SRPT as of Q1 2022.

  • Salem Investment Counselors reported no remaining Sarepta Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Salem Investment Counselors sold 201 Sarepta Therapeutics shares in Q1 2022, an estimated $18K.
  • Salem Investment Counselors first reported a position in Sarepta Therapeutics in Q3 2021 and held it in 2 quarters.
  • Salem Investment Counselors's Sarepta Therapeutics position peaked at $19K in Q3 2021.
  • 329 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2022.

Based on Salem Investment Counselors's 13F filing for Q1 2022, filed 16 May 2022.